Aug 07, 2025 • Motley Fool
SOMEWHAT-BULLISH
Certara ( CERT ) Q2 Revenue Jumps 12%
Certara ( NASDAQ:CERT ) , a leader in biosimulation software and Model-Informed Drug Development solutions, released its Q2 FY2025 earnings on August 6, 2025. The most notable news was a slight revenue beat, with reported GAAP revenue of $104.6 million, exceeding analyst expectations, but ...
Aug 06, 2025 • Zacks Commentary
NEUTRAL
Certara, Inc. ( CERT ) Q2 Earnings Miss Estimates
Certara (CERT) delivered earnings and revenue surprises of -30.00% and +0.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Aug 04, 2025 • GlobeNewswire
NEUTRAL
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling
Certara today announced that the European Medicines Agency has formally qualified the Simcyp® Simulator for use in regulatory submissions across the EU.
Aug 04, 2025 • Benzinga
NEUTRAL
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling - Certara ( NASDAQ:CERT )
RADNOR, Pa., Aug. 04, 2025 ( GLOBE NEWSWIRE ) -- Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency ( EMA ) has formally qualified the Simcyp® Simulator for use in regulatory submissions across the EU. Certara is the first company to receive EMA ...
Jul 31, 2025 • GlobeNewswire
BULLISH
Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform
RADNOR, Pa., July 31, 2025 ( GLOBE NEWSWIRE ) -- Certara, Inc. ( Nasdaq: CERT ) , a global leader in model-informed drug development, today announced the appointment of Christopher Bouton, Ph.D., as Chief Technology Officer.
Jul 31, 2025 • Benzinga
SOMEWHAT-BULLISH
Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform - Certara ( NASDAQ:CERT )
RADNOR, Pa., July 31, 2025 ( GLOBE NEWSWIRE ) -- Certara, Inc. CERT, a global leader in model-informed drug development, today announced the appointment of Christopher Bouton, Ph.D., as Chief Technology Officer.